Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaitianli Pharmaceutical Holdings Group is a prominent Chinese pharmaceutical company specializing in the development, manufacture, and sale of over-the-counter (OTC) medicines and nutritional supplements. The company is most famous for its namesake calcium supplement brand, Gaitianli, which has been a household name in China for decades. Beyond calcium products, the group produces a variety of treatments for respiratory conditions, including cough and cold remedies, as well as traditional Chinese medicine (TCM) formulations. Headquartered in Jiangsu Province, the company operates large-scale GMP-certified manufacturing facilities and maintains an extensive domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaitianli Pharmaceutical.